Pulmonary arterial hypertension before closure of a persistent arterial duct (PDA) in children <12 months: clinical implications and outcome
Background The management of patent ductus arteriosus (PDA) in infants with pulmonary hypertension (PH) remains controversial due to concerns regarding irreversible pulmonary vascular disease and post-closure hemodynamic deterioration. Evidence in children <12 months is limited. We aim to describe the hemodynamics and...